Who are Axiom Bio's investors?

Axiom Bio's investors include Abstract Ventures, Amplify Partners, Atria Ventures, CRV (Charles River Ventures), Gaingels, Inception Studio Capital, Mana Ventures, Dimension Capital.

Axiom Bio

Founded 2024 · 25 employees on LinkedIn · 8 known investors

Find your way into Axiom Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Axiom Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.

AI & Machine Learning Biotech Medical Devices

Founders & leadership

Alex BeatsonFounder

Brandon WhiteFounder

Investors · 8

Abstract Ventureslisted by Abstract VenturesSan Francisco · $250K – $750K

How we know: Abstract Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Amplify Partnerslisted by Amplify PartnersMenlo Park · $500K – $5M

How we know: Amplify Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Atria Ventureslisted by Atria VenturesSan Francisco · $500K – $3Mvia Chris Leiter · inferred

How we know: Atria Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

CRV (Charles River Ventures)listed by CRV (Charles River Ventures)Bay Area · $250K – $5M

How we know: CRV (Charles River Ventures)'s portfolio page · Not right? Tell us

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: gaingels.com · Not right? Tell us

Inception Studio Capitallisted by Inception Studio CapitalSilicon Valley · $100K – $1.5M

Mana Ventureslisted by Mana VenturesEstero

Dimension CapitalreportedSan Francisco · $1M – $10M

How we know: the VCSheet dataset · Not right? Tell us

Related companies · 3

Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

Axiom TherapeuticsAxiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations. The work is aimed at oncology research teams pursuing targets that have been difficult to drug.

AxiomAxiom is a fully managed, petabyte-scale event store and observability platform that ingests schema-less, high-cardinality event data and lets teams query it using its piped query language (APL). It targets engineering teams handling large log and telemetry volumes, positioned as an alternative to Splunk and Datadog, with native support for AI-agent querying.

Companies working in the same space as Axiom Bio.

Frequently asked questions

What does Axiom Bio do?: Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.
Who are Axiom Bio's investors?: Axiom Bio's investors include Abstract Ventures, Amplify Partners, Atria Ventures, CRV (Charles River Ventures), Gaingels, Inception Studio Capital, Mana Ventures, Dimension Capital.